University Health Network-ko ikertzaileekin lankidetzan egindako argitalpenak (17)

2024

  1. Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

    Liver International, Vol. 44, Núm. 1, pp. 250-262

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Cell-Specific Dysregulation of Iron and Oxygen Homeostasis as a Novel Pathophysiology in PSP

    Annals of Neurology, Vol. 93, Núm. 3, pp. 431-445

  3. Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial

    Nature Medicine, Vol. 29, Núm. 6, pp. 1370-1378

2022

  1. Acute kidney injury after cardiac surgery: Sustained low efficiency compared to continuous renal replacement therapy

    Journal of Clinical Anesthesia, Vol. 77

  2. Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy

    Translational Neurodegeneration, Vol. 11, Núm. 1

  3. HIGH THROUGHPUT 3D PRINTING OF TUBULAR MICROSTRUCTURES FROM ELASTOMERIC POLYMERS FOR ORGAN-ON-A-CHIP APPLICATIONS

    MicroTAS 2022 - 26th International Conference on Miniaturized Systems for Chemistry and Life Sciences

  4. Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria

    Journal of Cachexia, Sarcopenia and Muscle, Vol. 13, Núm. 5, pp. 2373-2382

  5. What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association

    JHEP Reports, Vol. 4, Núm. 12

2021

  1. Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma

    Future Oncology, Vol. 17, Núm. 11, pp. 1295-1310

  2. Pressure injury prediction models for critically-ill patients should consider both the case-mix and local factors

    Intensive and Critical Care Nursing

2019

  1. A phenotypical map of disseminated hepatocellular carcinoma suggests clonal constraints in metastatic sites

    Histopathology, Vol. 74, Núm. 5, pp. 718-730

2018

  1. A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

    Oncogene, Vol. 37, Núm. 27, pp. 3740-3752

2017

  1. Consistency and reproducibility of next-generation sequencing and other multigene mutational assays: A worldwide ring trial study on quantitative cytological molecular reference specimens

    Cancer Cytopathology, Vol. 125, Núm. 8, pp. 615-626

2016

  1. Hepatocellular carcinoma

    Nature Reviews Disease Primers, Vol. 2

2015

  1. Primary cystic peritoneal masses and mimickers: spectrum of diseases with pathologic correlation

    Abdominal Imaging, Vol. 40, Núm. 4, pp. 875-906

2014

  1. Population-based standardized symptom screening: Cancer Care Ontario's edmonton symptom assessment system and performance status initiatives

    Journal of Oncology Practice, Vol. 10, Núm. 3, pp. 212-214